Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P75
Within normal range
vs 2Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 32.59% |
| 2024 | 97.34% |
| 2023 | 14.97% |
| 2022 | -12.57% |
| 2021 | 0.00% |